Pharsight
Ask Pharsight
GLENMARK SPECIALTY SA PATENTS FACING OPPOSITIONS
Top patents of GLENMARK SPECIALTY SA facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3043773B1
30 Jun, 2021
Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone And Olopatadine
Sep, 2034
1